Mouse-adapted dengue type 4 virus (DEN4) strain H241 is highly neurovirulent for mice, whereas its non-mouse-adapted parent is rarely neurovirulent. The genetic basis for the neurovirulence of the mouseadapted mutant was studied by comparing intratypic chimeric viruses that contained the three structural protein genes from the parental virus or the neurovirulent mutant in the background sequence of nonneurovirulent DEN4 strain 814669. The chimera that contained the three structural protein genes from mouse neurovirulent DEN4 strain H241 proved to be highly neurovirulent in mice, whereas the chimera that contained the corresponding genes from its non-mouse-adapted parent was not neurovirulent. This finding indicates that most of the genetic loci for the neurovirulence of the DEN4 mutant lie within the structural protein genes. A comparison of the amino acid sequences of the parent and its mouse neurovirulent mutant proteins revealed that there were only five amino acid differences in the structural protein region, and three of these were located in the envelope (E) glycoprotein. Analysis of chimeras which contained one or two of the variant amino acids of the mutant E sequence substituting for the corresponding sequence of the parental virus identified two of these amino acid changes as important determinants of mouse neurovirulence. First, the single substitution of Ile for Thr-155 which ablated one of the two conserved glycosylation sites in parental E yielded a virus that was almost as neurovirulent as the mouse-adapted mutant. Thus, the loss of an E glycosylation site appears to play a role in DEN4 neurovirulence. Second, the substitution of Leu for Phe-401 also yielded a neurovirulent virus, but it was less neurovirulent than the glycosylation mutant. These findings indicate that at least two of the genetic loci responsible for DEN4 mouse neurovirulence map within the structural protein genes.
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The four serotypes of dengue virus form a distinct antigenic subgroup of some 70 members of the arthropod-borne, serologically related flaviviruses. These flaviviruses are now classified within the Flavivirus genus of the family Flaviviridae, which contains two other genera, the human hepatitis C virus genus and the Pestivirus genus (9) . Dengue viruses continue to cause major epidemics in most tropical and subtropical regions where the Aedes mosquito vector is abundant. Dengue virus infection usually causes fever, rash, and joint pain, but the disease is self-limited. However, in recent years, a more severe form of dengue, characterized by hemorrhagic fever and hemorrhagic shock, has occurred with increasing frequency, most notably in the dengue-epidemic region of southeast Asia (12) . This form of dengue has a high fatality rate, especially in children and young adults. A safe and effective vaccine against dengue has not been developed.
Various strategies have been explored to produce an effective vaccine for prevention of dengue virus infection ever since the dengue virus was isolated more than half a century ago. During early studies, serial intracerebral passage of dengue type 1 or type 2 virus in mice was used to attenuate these viruses for development of candidate strains for inclusion in a vaccine to be used in humans (16, (24) (25) (26) (27) . Studies by Hotta showed that the Mochizuki strain (dengue type 1) virus lost its virulence for humans after 17 passages in mouse brain (16 satisfactorily attenuated and induced a lasting protective immunity against virus of the same serotype (24, 25) . Sabin 's studies further demonstrated that continued passage in mice selected highly neurovirulent mutants which produced paralytic disease in monkeys (25) . Because of this increased neurovirulence, late-passage viruses were not considered safe for use as vaccines. However, these dengue viruses are valuable for use in studies designed to identify the genetic basis for loss of virulence for humans as well as the acquisition of neurovirulence for mice.
Following the construction of a full-length cDNA clone of dengue type 4 virus (DEN4) strain 814669, which can be used to produce infectious RNA transcripts (18), we recently constructed intertypic chimeric dengue viruses that contain the structural protein genes of DEN1 strain Western Pacific or DEN2 strain New Guinea C replacing the corresponding genes of DEN4 (3) . A study with suckling mice demonstrated that the DEN2-DEN4 chimeric virus containing the three structural protein genes from the neurovirulent DEN2 strain retained much of the neurovirulence of the parental DEN2 strain (3) . This suggested that most genetic determinants of mouse neurovirulence map within the three structural protein genes.
DEN4 strain H241 was first isolated during a dengue epidemic in the Philippines in 1956. Subsequent isolation of DEN4 from hemorrhagic fever patients as well as patients with classical dengue fever elsewhere in Asia indicated that DEN4 was an important pathogen (13, 14) . The first introduction of DEN4 into the Caribbean resulted in a large epidemic during 1980 to 1981 (15) . Since (20) . Mouse neurovirulence. DEN4 strains and intratypic DEN4 chimeras were evaluated for mouse neurovirulence as described before (3, 21) . For analysis of the 50% lethal dose (LD50), 3-day-old outbred Swiss mice in groups of 6 to 10 were inoculated intracerebrally with serial dilutions of DEN4 or its derived chimera at a dose of 1 to 103 PFU in 25 [lI of Eagle's basal medium with 0.25% human serum albumin. The survival rate analysis was also performed for the series of DEN4 parents and chimeric constructs at a fixed infectious dose. Briefly, 15 to 20 mice in each group were inoculated with a calculated dose of 125 PFU of DEN4 in the diluent mentioned above. Mice were then observed daily for signs of paralysis and death for 25 days postinoculation.
Titration of virus. The titers of the various DEN4 preparations were determined by a plaque assay on LLC-MK2 cells (1) . Briefly, monolayers of LLC-MK2 cells were inoculated with serial dilutions of virus and overlaid with Seakem ME agarose (FMC BioProducts, Rockland, Maine) containing medium 199 supplemented with 10% fetal bovine serum, basal amino acids, and vitamins. Cells were stained with neutral red 8 days after infection, and the number of plaques was counted the following day. AGA TTC TCA ACC GGA CTT TTT TCC GGG AAA GGA CCC TTA COO ATG GTG CTA GCA TTC ATC ACGO TTT TTG CGA GTC CTT TCG ATC CCA 
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FIG. 1. Nucleotide and encoded amino acid sequences of the structual protein gene region of prototype strain DEN4 H241. The nucleotide and amino acid positions are numbered according to the published sequence of DEN4 strain 814669 (30) . The N termini of the capsid protein (C), the precursor membrane protein (pre-M), and the envelope glycoprotein (E) are indicated by arrows. The potential N-linked glycosylation sites in this region are underlined. The sequences in the boxed region are from DEN4 strain 814669. Amino acid residues shown in boldface italic letters indicate differences from the neurovirulent mutant, as summarized in Table 1. widely separated geographic regions. The two viruses were In the 2,232-nt sequence encompassing nearly all of the distinct, as shown by an oligonucleotide fingerprint analysis structural protein gene region, there were 121 nucleotide and by the pattern of cross-neutralization with virus-specific differences (94.6% homology) between the two DEN4 strains. hyperimmune mouse ascitic fluid (15) . The DNA sequence of These were mostly silent changes, occurring in the third the three structural protein genes of DEN4 H241-P was position of a codon.
determined, and the deduced amino acid sequence (Fig. 1) was Comparison of amino acid sequences between the two compared with the published sequence of DEN4 814669 (30) . (H241-N) , that contained the BglIIXhoI DNA fragment of DEN4 H241-P or DEN4 H241-N, respectively, substituting for the corresponding sequence of DEN4 814669. Because three changes are located in the E region, experiments were designed to determine the role of each of these changes in neurovirulence. For this purpose, three additional chimeric cDNAs that contained a single amino acid substitution and a fourth containing double substitutions in E were prepared by site-directed mutagenesis or by replacement of appropriate DNA fragments. The structures of the chimeric constructs and their genotype designations are shown in Fig. 2 . Transfections of LLC-MK2 cells with RNA transcripts of these chimeric constructs all yielded progeny viruses, as detected by an IFA. This assay showed that approximately 75 to 100% of the cells were positive for dengue virus antigens on day 13 following transfection with RNA transcripts from p2A(H241-P), p2A(H241-P,I-155,P-156, p2A(H241-P,I-155), p2A(H241-P,P-156), or p2A(H241-P,L-401). The progeny viruses were harvested at day 20, and virus titers ranged from 4 x 104 to 2 x 105 PFU/ml. In contrast, only a few IFA-positive cells were observed on day 23 after transfection with RNA transcripts from p2A (H241-N) . The 4 and 80% by day 5, and most cells were positive for dengue virus antigens on day 6 . In contrast, parental DEN4 H241-N and its derived chimera exhibited a slow virus spread: only a few foci, each consisting of two to three positive cells, were detected on day 3, and the number of positive cells in the infected focus was 10 to 20 on day 4 and increased to 100 to 200 on day 7 . Approximately 70 to 80% of the cells were infected by day 11. Analysis of viral proteins. Radioactive [35S]methioninelabeled proteins prepared in C6/36 cells infected with DEN4 H241-P, DEN4 H241-N, or their derived chimeras were analyzed by immunoprecipitation with DEN4 hyperimmune mouse ascitic fluid and SDS-PAGE (Fig. 3) . DEN4 H241-P and its derived chimera produced labeled bands that were identified as the pre-M, E, NS1, and NS3 proteins. Similar analysis showed that DEN4 H241-N and its derived chimera produced NS1 and NS3 proteins that migrated to the same locations as the counterpart proteins from the prototype parent. The pre-M proteins of DEN4 H241-N and 2A(H241-N) were detected at a reduced level and migrated slightly slower than the pre-M of DEN4 H241-P. The E glycoproteins of DEN4 H241-N and 2A(H241-N) migrated faster than the E protein of DEN4 H241-P or 2A(H241-P) (Fig. 3A) . The calculated size difference between the two E proteins was about 3 kDa, a value equivalent to one carbohydrate moiety. The molecular size reduction observed for the E proteins of DEN4 H241-N and 2A(H241-N) was predicted, because the Thr-155-->Ile substitution removes the potential N-glycosylation site at position 153 of E.
The E proteins were immunoprecipitated with an anti-DEN4 E peptide serum and further analyzed by digestion with endoglycosidase F (Fig. 3B) . The result showed that the E , which contains a complete cDNA copy of DEN4 strain 814669, was the basis for construction of all chimeric DEN4 cDNAs from the convenient XhoI site created near the 3' end of the E protein gene (3) . p2A(H241-P) contains the structural protein gene defined by the sequence between the BglII site at nt 88 and the XhoI site of the DEN4 H241 parent; p2A(H241-N) contains the above-defined structual protein gene from the mouse-neurovirulent DEN4 H241 mutant. Plasmids p2A(H241-P,I-155,P-156), p2A(H241-P,I-155), p2A(H241-P,P-156), and p2A(H241-P,L-401) contain the same sequence as in p2A(H241-P) and the mutations specifying the indicated amino acid substitution in the E protein of the neurovirulent mutant. The mutations in the first three constructs were introduced by mutagenesis with an oligonucleotide-driven PCR. The mutation in the last construct, specifying a Leu substitution at position 401, was introduced by replacing the BsEII-XhoI fragment of DEN4 H241-P with the corresponding cDNA fragment of DEN4 H241-N.
M, DEN4 (814669); DEN4 (H241 parent prototype); DEN4 (H241 neurovirulent mutant).
protein products of DEN4 H241-P and DEN4 H241-N were sensitive to endoglycosidase F digestion, and the sizes of both proteins appeared to be the same after digestion. This indicates that at least one of the two remaining potential N-glycosylation sites in DEN4 H241-N E protein is functional. On the other hand, the observed difference in the size of pre-M between the DEN4 H241-P and H241-N strains could not be explained by the conservative Val-78 to Ala substitution alone. Because DEN4 H241-N E glycosylation was altered, it was possible that pre-M could undergo differential posttranslational modification as a consequence of interaction with the E protein.
The viral proteins produced by other chimeric DEN4 viruses containing one or two amino acid substitutions in the E protein were also analyzed (Fig. 4) . The results showed that 2A(H241-P) and two of its chimeric derivatives, 2A(H241-P,P-156) and 2A(H241-P,L-401), produced viral proteins of identical sizes. The E proteins produced by 2A(H241-P,I-155,P-156) and by 2A(H241-P,I-155) migrated faster than the E protein of 2A(H241-P), as predicted, because the glycosylation site sequence was removed.
Genetic loci determining DEN4 mouse neurovirulence. Three-day-old suckling mice were used to evaluate the neurovirulence of the 2A(XhoI), DEN4 H241-P, and H241-N strains and the derived chimeras 2A(H241-P) and 2A (H241-N) . Two of 46 suckling mice inoculated intracerebrally with 1,000 PFU of 2A(XhoI) died of encephalitis on days 11 and 20. The mortality rate (4.3%) was similar to the result obtained previously (3). In the same experiment, 3 of 22 mice (14%) inoculated with 1,000 PFU of DEN4 H241-P died between days 7 and 10, and 1 of 24 mice (4%) inoculated with the same dose of 2A(H241-P) died on day 19. The difference in mortality among the infected mouse groups was not significant (P > 0.25 by a X2 test) ( Table 2 ). Fewer than 50% of the animals died even at the highest dose (1,000 PFU) tested. The LD5() of DEN4 814669, H241-P, and its derived intratypic chimera was greater than 1,000 PFU. DEN4 H241-N proved to be highly neurovirulent; the calculated LD50 was 0.6 PFU. Chimera 2A(H241-N) also proved to retain most of the mouse neurovirulence of its parent DEN4 H241-N; the calculated LD50 of the virus was 23.3 PFU.
We also analyzed the mouse neurovirulence of chimeras engineered to contain single or double amino acid substitutions in the 2A(H241-P) genetic background. The results (Table 2) showed that chimera 2A(H241-P,P-156) was not neurovirulent, as the mortality rate of mice inoculated with 1,000 PFU of this virus did not differ from that of mice inoculated with its parent 2A(H241-P). Chimera 2A(H241-P,L-401) exhibited a moderate increase in neurovirulence, as the LD50 of 91.7 PFU was much lower than that of nonneurovirulent 2A(H241-P) but higher than that of neurovirulent 2A (H241-N) . Chimeras 2A(H241-P,I-155,P-156) and 2A (H241-P,I-155) were both neurovirulent, with an LD50 of 23.1 and 2.6 PFU, respectively. These results provide evidence that both the Thr-155 to Ile and Phe-401 to Leu mutations in the DEN4 E sequence were determinants of DEN4 mouse neurovirulence. A comparison of neurovirulence suggests that Thr at position 155 is the most important determinant for the DEN4 neurovirulence phenotype in mice.
Animals were also inoculated intracerebrally with each virus at a dose of 125 PFU, and the Kaplan-Meier survival curves were compared (Fig. 5) . While most mice inoculated with the nonneurovirulent parent or its derived chimera survived for the 25-day observation period, all 15 mice inoculated with neurovirulent DEN4 H241-N died 7 to 11 days after inoculation. In the same experiment, 16 of 19 mice (84%) died between 10 and 15 days after inoculation with chimera 2A (H241-N) . According to the Smirnov statistic, the difference between the survival distributions for DEN4 H241-N and its derived chimera 2A(H241-N) is highly significant (P < 10-6), implying that the nonstructural region contributes to mouse neurovirulence. The groups infected with 2A(H241-P, L-401) (P < 0.005), 2A(H241-P,I-155,P-156) (P < 0.001), and 2A (H241-P,I-155) (P < 10-6) were each significantly different from the group infected with 2A(H241-P). Similarly, the difference between the 2A(H241-P) and the 2A(H241-P,P-156) groups was highly significant (P < 10-6). These data are consistent with the results of the LD50 analysis described above. On the basis of this test, the survival curve for 2A(H241-P,I-155,P-156) is significantly different from that for 2A(H241-P,I-155) (P < 0.05). This observation suggests that the substitution of Pro for Ser-156 reduced the effect of the Ile-155 neurovirulence mutation.
DISCUSSION
Previously, mouse-neurovirulent mutants of dengue type 1, 2, and 4 viruses were selected by serial intracerebral passage of wild-type human dengue viruses in mice. These neurovirulent dengue virus mutants have been used primarily as challenge viruses in experimental mouse immunoprophylaxis studies. However, these mutants should also prove useful for mapping the genetic loci responsible for mouse neurovirulence. Previous studies of intertypic chimeric dengue viruses constructed by using DEN4 cDNA as a vector indicated that at least some genetic determinants for the mouse-neurovirulent phenotype of DEN2 strain NGC were located in its structural protein genes (3) .
In the current study, we pursued this question in a more systematic manner by analyzing the genetic loci for mouse neurovirulence of DEN4 strain H241. This was achieved by constructing intratypic chimeric viruses that contained the three structural protein genes from this virus mutant or its nonneurovirulent parental virus. The chimera that contained the structural protein genes from the neurovirulent DEN4 H241 proved to be highly neurovirulent, whereas the chimera that contained the corresponding genes from the parent DEN4 H241 was not neurovirulent. This observation indicates that most of the genetic loci responsible for the neurovirulent phenotype of mouse-adapted DEN4 H241 map within the structural protein genes. The contribution of the noncoding and nonstructural protein gene regions to DEN4 mouse neurovirulence has not been examined. Analysis of mouse neurovirulence revealed that the LD50 of the neurovirulent mutant H241-N was slightly higher than that of the chimera 2A(H241-N), which contains the structural genes of H241-N in the background of nonneurovirulent DEN4 strain 814669. In addition, the mean day of death was also significantly different between the two viruses. These data are consistent with the notion that genetic loci outside the structural protein genes may also contribute to DEN4 mouse neurovirulence.
Despite numerous passages in mouse brain, the neurovirulent DEN4 H241 mutant differed from the parental virus at only five codons in the structural protein region. This observation suggests that the genotype of the neurovirulent DEN4 H241 had stabilized. Three of these amino acid changes in the neurovirulent mutant were located in the E protein sequence: Ile substituting for Thr-155, Pro for Ser-156, and Leu for Phe-401. Analysis of intratypic chimeras containing one or two of these changes constructed by site-directed mutagenesis allowed us to identify two specific changes that were responsible for neurovirulence. Specifically, the single substitution of Ile for Thr-155 which ablated one of the two conserved potential glycosylation sites in dengue virus E yielded progeny virus that was almost as neurovirulent as DEN4 H241-N. The available evidence did not permit distinction between the possibilities that the substitution of Ile itself or the loss of E glycosylation was responsible for neurovirulence. To answer to this question, we conducted a similar study which showed that a single substitution of Ala for Thr-155 at the corresponding glycosylation site of DEN4 strain 814669 also converted the nonneurovirulent parent to a neurovirulent virus (17a (5, 6) . Host-specific as well as virus strain-specific differences in E glycosylation have been noted for yellow fever virus (8, 23 (7, 10, 11, 17, 19, 21, 30) as well as other flaviviruses. Leu substitution at position 401 of the neurovirulent DEN4 mutant resulted in a change from an aromatic amino acid to an aliphatic amino acid. It is of interest that an Ile substitution for Phe-401 occurred during the selection of a neurovirulent mutant from non-neurovirulent parental DEN2 New Guinea C during serial intracerebral passage in mice (3a) .
On the basis of the Smirnov test, the difference in the survival distributions between the mouse groups infected with 2A(H241-P) and 2A(H241-P,P-156) had a P value of less than (16, 24, 27) . Analysis of amino acid changes in these viruses during serial mouse brain passage might help to identify other sequences that confer attenuation for humans and at the same time contribute to mouse neurovirulence.
